<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04548674</url>
  </required_header>
  <id_info>
    <org_study_id>UFPara-008</org_study_id>
    <nct_id>NCT04548674</nct_id>
  </id_info>
  <brief_title>Analysis of the Influence of Desensitizing Treatments on the Pulp Inflammatory Response in Bleached Teeth</brief_title>
  <official_title>Effect of Different Desensitizing Protocols on the Pulp Inflammatory Response in Bleached Teeth: A Randomized Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal do Para</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidade Federal do Para</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized, controlled, blinded clinical trial evaluated the effectiveness of different&#xD;
      desensitizing protocols in preventing pulp inflammation after bleaching treatment with 35%&#xD;
      hydrogen peroxide (PH) (Whiteness PH 35%).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thirty healthy third human molars extracted by orthodontic indication were randomized and&#xD;
      allocated into five groups (n = 6): CN (negative control): without intervention; CP (Positive&#xD;
      control): PH; PMB: PH + photobiomodulation with low power laser; CPP: PH + casein&#xD;
      phosphopeptide phosphopeptide amorphous calcium phosphate (CPP-ACPF); NANO: PH +&#xD;
      nanohydroxyapatite. The office whitening was performed in two sessions with a single&#xD;
      application of 45 min and an interval of 48 hours between them. Pulp tissues were removed for&#xD;
      immunohistochemical analysis. Immunostaining was performed for Caspase 3 using an Axio&#xD;
      Scope.A1 microscope.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 20, 2018</start_date>
  <completion_date type="Actual">June 30, 2019</completion_date>
  <primary_completion_date type="Actual">March 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pulp inflammation</measure>
    <time_frame>3 days After extraction of third molars</time_frame>
    <description>Evaluation of pulp inflammation through immunohistochemistry of the third molar whitening or not</description>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Pulp Inflammation</condition>
  <arm_group>
    <arm_group_label>Positive Control Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Whiteness HP 35%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laser Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Whiteness HP 35% + Laser</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CPP Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Whiteness HP 35% + CPP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nano Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Whiteness HP 35% + NANO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Negative Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Without intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Whiteness HP 35%</intervention_name>
    <description>Single application of 45 minutes on the buccal surfaces of third molars, with an average thickness of 1 mm</description>
    <arm_group_label>CPP Group</arm_group_label>
    <arm_group_label>Laser Group</arm_group_label>
    <arm_group_label>Nano Group</arm_group_label>
    <arm_group_label>Positive Control Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Whiteness HP 35% + LASER</intervention_name>
    <description>A dose of LASER (60 J / cm2, for 16 seconds) was applied at two points, one point in the cervical region and another in the center of the buccal surface of the third molars, using visible infrared LASER therapy (Photon III / DMC, São Carlos, SP, Brazil), with a wavelength of 808 nm, and AsGaAl, as an active medium.</description>
    <arm_group_label>Laser Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Whiteness HP 35% + CPP</intervention_name>
    <description>Topical application of casein phosphopeptide amorphous calcium phosphate fluoride CPP-ACPF (My Paste Plus, Recaldent, GC, USA) with the aid of a microbrush (KG Sorensen, SP, Brazil) in a passive way for 5 minutes.</description>
    <arm_group_label>CPP Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Whiteness HP 35% + NANO</intervention_name>
    <description>A topical application of nanohydroxyapatite (Nano P FGM, SC, Brazil) was performed with the aid of a microbrush (KG Sorensen, SP, Brazil) in a passive way for 5 minutes after teeth whitening.</description>
    <arm_group_label>Nano Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Lower third molars class I position A&#xD;
&#xD;
          -  Maxillary third molars horizontal position A&#xD;
&#xD;
          -  Absence of caries and enamel fracture&#xD;
&#xD;
          -  Absence of periodontal disease&#xD;
&#xD;
          -  Extraction of third molars for orthodontic reasons&#xD;
&#xD;
          -  No allergy to the anesthetic and positive pulp sensitivity test&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Calcification in the middle third of the root&#xD;
&#xD;
          -  Drug users or smokers&#xD;
&#xD;
          -  Patients who have already done whitening&#xD;
&#xD;
          -  Root apex with incomplete formation and patients with systemic problems that would&#xD;
             make surgery impossible&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>26 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Universidade Federal do Pará</name>
      <address>
        <city>Belém</city>
        <state>Pará</state>
        <zip>66075-110</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 1, 2020</study_first_submitted>
  <study_first_submitted_qc>September 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2020</study_first_posted>
  <last_update_submitted>September 8, 2020</last_update_submitted>
  <last_update_submitted_qc>September 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal do Para</investigator_affiliation>
    <investigator_full_name>Cecy Martins Silva</investigator_full_name>
    <investigator_title>Professor Clínico</investigator_title>
  </responsible_party>
  <keyword>Therapies</keyword>
  <keyword>Caspase 3</keyword>
  <keyword>Immunohistochemistry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

